Kaligent - part of TGen

What We Do - Kaligent provides software products and services designed to help healthcare and life science customers derive data-driven insights that impact patient care and outcomes. About Kaligent - As a wholly owned subsidiary of TGen - a part of City of Hope, an institute with a legacy rooted in genomic research, translational discovery, and high performance computing, Kaligent is uniquely positioned to commercialize its IP for pharma, payers, and providers. Our work seeks to redefine the patient care experience and advocate for greater data stewardship, security and management. Partnered with key technology providers, Kaligent seeks to democratize data and insights by providing flexible consumption models for agile, cost-effective solution deployments driving innovation that benefits all of humanity. We are currently looking to collaborate and engage with forward looking institutions interested in how we are transforming the industry.